Nonocclusive Mesenteric Ischemia after Chemotherapy in an Adolescent Patient with a History of Three Allogeneic Hematopoietic Stem Cell Transplantations for Acute Lymphoblastic Leukemia
Nonocclusive mesenteric ischemia (NOMI) is induced by intestinal vasospasm without thromboembolic occlusion and is associated with high morbidity and mortality. The estimated overall incidence of autopsy-verified fatal NOMI is 2.0 cases/100,000 person-years; however, no pediatric or adolescent cases have yet been reported. An 18-year-old female was diagnosed with B-cell precursor acute lymphoblastic leukemia at the age of 10 years. Our patient received three allogeneic hematopoietic stem cell transplantations but experienced hematological relapse after each.
Source: Pediatrics and Neonatology - Category: Perinatology & Neonatology Authors: Koichi Hirabayashi, Mitsuho Takatsuki, Mitsuo Motobayashi, Takashi Kurata, Shoji Saito, Tomonari Shigemura, Yozo Nakazawa, Kazuo Sakashita, Satoshi Ishizone, Hiroyoshi Ota, Kenichi Koike Tags: Case report Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Chemotherapy | Hematology | Leukemia | Pediatrics | Perinatology & Neonatology | Stem Cell Therapy | Stem Cells | Transplants